Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Cardiotoxicity 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cisplatin 20Cetuximab 11Carboplatin 9Specimen Handling 8Radiotherapy 8Docetaxel 8Radiotherapy, Intensity-Modulated 7Magnetic Resonance Spectroscopy 71,2-diaminocyclohexaneplatinum II citrate 7Platinum 6Fluorouracil 6pembrolizumab 5Radiation 5toripalimab 4Paclitaxel 4cemiplimab 3X-Rays 3Surgical Procedures, Operative 3Celecoxib 3Biopsy 3130-nm albumin-bound paclitaxel 3Taxes 2Standard of Care 2Radiotherapy, Image-Guided 2Hydroxyurea 2Drug Therapy 2tislelizumab 1sodium thiosulfate 1sargramostim 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Laryngeal Neoplasms × Fluorophotometry × Clear all
NCT00002964 2013-02-05

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

Roswell Park Cancer Institute

Phase 2 Completed
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡